Prediction of Drug Combinations by Integrating Molecular and Pharmacological Data

Open Access

Peer-reviewed

Research Article

Xing-Ming Zhao,

Affiliation European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⨯
Murat Iskar,

Affiliation European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⨯
Georg Zeller,

Affiliation European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⨯
Michael Kuhn,

Affiliation Biotechnology Center, Technical University Dresden, Dresden, Germany
⨯
Vera van Noort,

Affiliation European Molecular Biology Laboratory (EMBL), Heidelberg, Germany
⨯
Peer Bork

* E-mail: bork@embl.de

Affiliations European Molecular Biology Laboratory (EMBL), Heidelberg, Germany, Max-Delbrück-Centre for Molecular Medicine, Berlin, Germany
⨯

x

Viewed

Powered by Altmetric

Questions or concerns about usage data? Please let us know.

Print

Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
ACE inhibitor therapy
Is the Subject Area "ACE inhibitor therapy" applicable to this article?

Thanks for your feedback.
Adverse reactions
Is the Subject Area "Adverse reactions" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.
Drug discovery
Is the Subject Area "Drug discovery" applicable to this article?

Thanks for your feedback.
Drug information
Is the Subject Area "Drug information" applicable to this article?

Thanks for your feedback.
Drug screening
Is the Subject Area "Drug screening" applicable to this article?

Thanks for your feedback.
NSAIDs
Is the Subject Area "NSAIDs" applicable to this article?

Thanks for your feedback.